Bank of America
TBPH icon

Bank of America’s Theravance Biopharma TBPH Stock Holding History

Bank of America’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23,100
Closed -$791K – 7249
2017
Q3 		$791K Buy
+23,100
New +$755K ﹤0.01% 4658
2014
Q4 		– Sell
-200
Closed -$5K – 7949
2014
Q3 		$5K Sell
200
-800
-80% -$23.2K ﹤0.01% 7554
2014
Q2 		$32K Buy
+1,000
New +$30.1K ﹤0.01% 6936

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's TBPH Position: Q1 2026 in Review

Bank of America increased its Theravance Biopharma (TBPH) stake by 78% in Q1 2026, buying an estimated $1.47M and bringing the position to 189,155 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3819.

Bank of America first reported a position in TBPH in Q2 2014 and has held it in 48 quarters since. The position peaked at $19.3M in Q1 2023. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Bank of America held 189,155 shares of Theravance Biopharma worth $3.07M as of Q1 2026.
  • Bank of America bought 82,978 Theravance Biopharma shares in Q1 2026, an estimated $1.47M.
  • Theravance Biopharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3819 holding.
  • Bank of America first reported a position in Theravance Biopharma in Q2 2014 and has held it in 48 quarters since.
  • Bank of America's Theravance Biopharma position peaked at $19.3M in Q1 2023.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.